Shanghai Junshi Biosciences' Toripalimab NDA Accepted by Hong Kong DO for Groundbreaking Nasopharyngeal Carcinoma Treatment

Shanghai Junshi Biosciences , a leading innovation-driven biopharmaceutical company dedicated to the discovery, development, and commercialization of novel...

April 25, 2024 | Thursday | News
Sanofi's Breakthrough BTK Inhibitor Shows Promise for Patients with Persistent and Chronic ITP, Regulatory Submissions Expected Soon

Rilzabrutinib LUNA 3 phase 3 study met primary endpoint in immune thrombocytopenia Pivotal data from the first phase 3 study of a BTKi in immune thrombo...

April 23, 2024 | Tuesday | News
INTERPHEX 2024 Sheds Light on Cutting-Edge Solutions: Leveraging AI for Fraud Detection in Pharma

Conference Session Recap: Leveraging AI for Fraud Detection in Pharma - Insights from INTERPHEX 2024  Attendees at INTERPHEX 2024 were treated to a t...

April 16, 2024 | Tuesday | News
Cytiva to Showcase Cutting-Edge Bioprocessing Innovations at INTERPHEX 2024

Cytiva, a global leader in life sciences solutions, proudly announces its participation at INTERPHEX 2024, where it will unveil its latest advancements in ...

April 16, 2024 | Tuesday | News
SaniSure accelerates drug speed to market with Fill4Sure launch

Fill4Sure™ provides an innovative solution to the critical challenges drug manufacturers experience throughout the fill-finish process, such as high ...

April 12, 2024 | Friday | News
ACROBiosystems Launches Organoid Toolbox to Advance Organoid Research

Observation: ACROBiosystems' relentless commitment to innovation and strategic partnerships underscores its pivotal role in advancing organoid research and...

April 10, 2024 | Wednesday | News
Sartorius and TheWell Bioscience Partner to Enable More Accurate Predictions in Drug Discovery

Collaboration to advance TheWell Bioscience animal-free hydrogel solutions for 3D cell models Solutions address shift from animal-based to more human-re...

April 09, 2024 | Tuesday | News
Shorla Oncology's Palatable Oral Liquid for Leukemia Enters FDA Review Process

Shorla Oncology (‘Shorla’), a U.S.-Ireland specialty pharmaceutical company, announced  that the U.S. Food and Drug Administration (FDA) h...

April 08, 2024 | Monday | News
Nucleai and GoPath Diagnostics Partner to Advance Digital Pathology with AI Integration

Nucleai, a spatial AI biomarker company that deciphers cellular conversations and maps cellular interactions within tissue samples to predict therapeutic o...

April 08, 2024 | Monday | News
dsm-firmenich and OMG Pharma Collaborate on CBD-Based Insomnia Drugs

Leveraging dsm-firmenich’s high quality GMP CBD active pharmaceutical ingredient (API) and leading-edge formulation capabilities, chiefly its bioavai...

April 03, 2024 | Wednesday | News
Bristol Myers Squibb’s Reblozyl® Receives Expanded EU Approval for LR-MDS Treatment

  Bristol Myers Squibb (NYSE: BMY) has announced the European Commission's (EC) expanded approval of Reblozyl® (luspatercept) for the first-line ...

April 03, 2024 | Wednesday | News
Innovent Biologics and HUTCHMED Announce Priority Review for Novel Combination Therapy in Advanced Endometrial Cancer

Innovent Biologics, Inc. ("Innovent") (HKEX: 01801), a world-class biopharmaceutical company that develops, manufactures and commercializes high quality me...

April 02, 2024 | Tuesday | News
Voydeya Approved as Add-On Therapy for Rare PNH Treatment in the US

Voydeya (danicopan) has been granted approval in the United States as an add-on therapy for the treatment of extravascular haemolysis (EVH) in adults diagn...

April 02, 2024 | Tuesday | News
LISCure Biosciences' LB-P8 Granted Fast Track Designation by FDA for Primary Sclerosing Cholangitis Treatment

LISCure Biosciences, a leading clinical-stage biopharmaceutical company focused on discovering and developing innovative microbiome-based therapies, a...

April 01, 2024 | Monday | News

Survey Box

Poll of the Week

Which area of biopharmaceutical research excites you the most?

× Please select an option to participate in the poll.
Processing...
× You have successfully cast your vote.
 {{ optionDetail.option }}  {{ optionDetail.percentage }}%
 {{ optionDetail.percentage }}% Complete
More polls
Stay Connected

Sign up to our free newsletter and get the latest news sent direct to your inbox

© 2025 Biopharma Boardroom. All Rights Reserved.

Show

Forgot your password?

Show

Show

Lost your password? Please enter your email address. You will receive a link to create a new password.

Back to log-in

Close